Evidence map›Paper›PMID 38371384›Full record

ArticleTherapeutic advances in neurological disorders2024

Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis.

Simon Faissner, Marielena Bongert, Paulina Trendelenburg, Sandra Thiel, Takashi Yamamura, Kerstin Hellwig, Ralf Gold

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in neurological disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Simon FaissnerDepartment of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, Bochum 44791, Germany.ORCID https://orcid.org/0000-0002-3412-762X
Marielena BongertDepartment of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Bochum, Germany.
Paulina TrendelenburgDepartment of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Bochum, Germany.
Sandra ThielDepartment of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Bochum, Germany.
Takashi YamamuraDepartment of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.
Kerstin HellwigDepartment of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Bochum, Germany.
Ralf GoldDepartment of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Bochum, Germany.ORCID https://orcid.org/0000-0002-7223-3052
St. Josef-Hospital · DENational Center of Neurology and Psychiatry · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pregnancy in patients with multiple sclerosis (MS) is accompanied by a decline of relapse activity with increased risk of relapses 3 months post-partum, for unknown reasons. Eomesodermin Objectives: Here, investigated immune cell alterations and the pathophysiological role of Eomes Methods: We enrolled Results: While CD3 Discussion: Pregnancy in MS is associated with robust immunological alterations. Eomes

Indexed as

Eomesodermin+ Th cellsmultiple sclerosispregnancyprogression independent of relapse activity

Identifiers

PMID38371384
PMCPMC10874138
OpenAlexW4391890708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.